Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 425
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00039364 | Imatinib Mesylate in Treating Patients With Gliomas | ||
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | ||
| NCT00003982 | MEN-10755 in Treating Patients With Solid Tumors | ||
| NCT00014586 | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | ||
| NCT00039351 | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma | ||
| NCT00003159 | Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | ||
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | ||
| NCT01344018 | Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma | ||
| NCT05815927 | Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | ||
| NCT03818997 | Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer | ||
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | ||
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | ||
| NCT00085475 | Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma | ||
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | ||
| NCT00020839 | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain | ||
| NCT03260712 | Pembrolizumab in Biliary Tract Cancer | ||
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | ||
| NCT00006230 | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | ||
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia | ||
| NCT03470350 | Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer | ||
| NCT04270123 | An EORTC Study Updating the QLQ-BR23 to BR45 | ||
| NCT00458913 | Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | ||
| NCT04031677 | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | ||
| NCT00005868 | Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer | ||
| NCT01969578 | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | ||
| NCT00028743 | Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | ||
| NCT02436733 | Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM | ||
| NCT01244789 | Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer | ||
| NCT00074087 | Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides | ||
| NCT03515993 | Follow-up in Gynecological Cancer Survivors | ||
| NCT01795521 | LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC | ||
| NCT03437200 | Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer | ||
| NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | ||
| NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | ||
| NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | ||
| NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | ||
| NCT04127110 | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients | ||
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | ||
| NCT00005061 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | ||
| NCT06219317 | Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC | ||
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT00887146 | Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma | ||
| NCT01658527 | TAK-700 in Castration Resistant Prostate Cancer | ||
| NCT00086879 | Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT02467582 | Adjuvant Aspirin Treatment for Colon Cancer Patients | ||
| NCT01164189 | Bevacizumab in Recurrent Grade II and III Glioma | ||
| NCT06462963 | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT) | ||
| NCT00085059 | Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma | ||
| NCT00002462 | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease |
